Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptomic analysis of senescent cells treated with Cardiac glycosides

ABSTRACT: Transcriptomic analysis of senescent cells treated with Cardiac glycosides

PROVIDER: PRJNA503415 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR8145420.fastq.gz	Fastqsanger.gz
	SRR8145430.fastq.gz	Fastqsanger.gz
	SRR8145440.fastq.gz	Fastqsanger.gz
	SRR8145450.fastq.gz	Fastqsanger.gz
	SRR8145421.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 36

Similar Datasets

Transcriptomic analysis of senescent cells and liver treated with Cardiac glycosides

Project description:Transcriptomic analysis of senescent cells and liver treated with Cardiac glycosides

| PRJNA503411 | ENA

Transcriptome analysis of human iPSC-neurons treated with cardiac glycosides

Project description:Transcriptome analysis of human iPSC-neurons treated with cardiac glycosides

| PRJNA949526 | ENA

Transcriptome analysis of human iPSC-neurons treated with cardiac glycosides

Project description:To investigate the molecular mechanisms of cardiac glycosides’ neuroprotection, we profiled transcriptomes of human iPSC-neurons after 72h of treatment with increasing doses of digoxin, oleandrin, proscillaridin A or vehicle alone (0.1% DMSO) using RNA sequencing.

2023-10-19 | GSE228348 | GEO

Transcriptomic analysis of senescent cells treated with Cardiac glycosides

Project description:IMR90 ER:RAS cells were treated with 4OHT to induce senescence. 6 days later they were treated with Vehicle, Ouabain or Digoxin for 16 or 36h and collected he cells were collected for total mRNA analysis. Minus (Cell not treated with 4OHT), Plus (Cell treated with 4OHT and vehicle), Plus C (On to pof the aforementiones treatments, cells were treated with Caspase inhibitors O/N)

2019-09-03 | GSE122079 | GEO

Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone

Project description:Normal human cardiac fibroblast were treated with 200 nM halofuginone for 24 hours and the transcriptomic profile was measured by RNAseq.

2017-03-03 | GSE95059 | GEO

Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells

Project description:Prostate cancer is the most common cancer in men and cardiac glycosides inhibit prostate cancer cell proliferation. In order to investigate the mechanism by which cardiac glycosides inhibit prostate cancer cells, we observed genome-wide RNA expression in prostate cancer LNCaP-abl cells, hormone resistant cells, after the cardiac glycoside treatment using RNA-Seq. In addition, we profiled LNCaP-abl cells after androgen receptor (AR) knockdown to observe whether cardiac glycoside effect on RNA expression is similar to that of AR knockdown. Observation of three cardioglycosides, Digoxin, Peruvoside and Strophanthidin, and AR knockdown regulated RNA expression in LNCaP-abl with RNA-Seq (each triplicates)

2012-04-03 | E-GEOD-35126 | biostudies-arrayexpress

Proteomic analysis of GC7-treated senescent and proliferating BJ fibroblasts

Project description:Quantitative analysis of global proteomic changes in proliferating and senescent BJ fibroblasts, treated with eIF5A hypusination inhibitor GC7 (10 uM) for 12h.

2024-07-12 | PXD034251 | Pride

Proteomics data of DMC-treated senescent cells

Project description:Three groups of cells, including the control group, the senescent cells group, and the DMC-treated senescent cells group

2023-11-23 | PXD047192 |

Transcriptomic and immunopepdidomic analysis of senescent and non-senescent mouse embryonic fibroblasts (MEF)

Project description:Transcriptomic and immunopepdidomic analysis of senescent and non-senescent mouse embryonic fibroblasts (MEF)

| PRJNA834062 | ENA

Nascent proteome analysis of proliferating and senescent BJ fibroblast treated with GC7

Project description:Analysis of proteomic changes in proliferating and senescent BJ fibroblast treated with eIF5A hypusination inhibitor GC7 for 12h.

2024-07-12 | PXD034334 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data